ORLANDO, Fla. (AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work....
zetiaStudy raises new questions about Merck pill ZetiaHeadlines from the Associated Press Sun, 11/15/2009 - 17:16
ORLANDO, Fla. (AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.... Tags:
Aggressive Lipid Lowering Controls Atherosclerosis EffectsMedPage Today Infectious Disease Thu, 12/04/2008 - 09:02
WASHINGTON (MedPage Today) -- Diabetic patients who reached aggressive lipid-lowering targets saw nearly identical vascular benefits whether on high-dose statins alone or with ezetimibe (Zetia), researchers found. Survey Report: Many Doctors Stand by Ezetimibe (Zetia)MedPage Today Surveys Fri, 04/11/2008 - 15:41
A sizeable minority of doctors continues to believe that ezetimibe (Zetia) is a powerful agent for their patients, according to a MedPage Today poll. |